Difference between revisions of "Part:BBa K3221009"
Line 19: Line 19:
  
 
'''iGEM19_SCU-China:'''  
 
'''iGEM19_SCU-China:'''  
−
<div  style="font-size:19px;">wrwrwrwrwrwrwrwrw</div>
+
<div  style="font-size:19px;">
 
This part is pGAL1-HisG-MF, which is a CDS of HisG-MF with a pGAL1 promoter upstream and a CYC1 terminator downstream. HisG-MF is half of Cns3 containing the HisG domain, which is designed from the reference and has been validated by 2019 SCU-China for expression and function in other fungus.
 
This part is pGAL1-HisG-MF, which is a CDS of HisG-MF with a pGAL1 promoter upstream and a CYC1 terminator downstream. HisG-MF is half of Cns3 containing the HisG domain, which is designed from the reference and has been validated by 2019 SCU-China for expression and function in other fungus.
  
 
Cns3 is an enzyme originated from ''Cordyceps militaris'', it catalyzes the biosynthesis of Pentostatin (2’-deoxycoformycin, PTN), an ada chemotherapeutic drug used for the treatment of several forms of leukemia.It has been proved that PTN can protect the stability of cordycepin from deamination by inhibiting adenosine deaminase (ADA) activity in the natural pathway of COR in ''C.militaris''.Therefore, in our designs, we make use of Cns3, producing PTN together with COR in order to guarantee a high yield of COR.Previous studies have also proved that the NK domain of Cns3, one of it's two function domains, is responsible for PTN biosynthesis, which is why we only use part of Cns3.  
 
Cns3 is an enzyme originated from ''Cordyceps militaris'', it catalyzes the biosynthesis of Pentostatin (2’-deoxycoformycin, PTN), an ada chemotherapeutic drug used for the treatment of several forms of leukemia.It has been proved that PTN can protect the stability of cordycepin from deamination by inhibiting adenosine deaminase (ADA) activity in the natural pathway of COR in ''C.militaris''.Therefore, in our designs, we make use of Cns3, producing PTN together with COR in order to guarantee a high yield of COR.Previous studies have also proved that the NK domain of Cns3, one of it's two function domains, is responsible for PTN biosynthesis, which is why we only use part of Cns3.  
 
<p>As is mentioned above, this part is an expression cassette of HisG-MF that is half of Cns3 containing the HisG domain. 2019 SCU-China validated its both in expression and function in  ''Saccharomyces cerevisiae''.To verify it’s function, we did RT-qPCR to detect the existence of Cns3-MF mRNA. (Figure. 1) As for function validation, we performed HPLC to detect PTN, the catalysate of Cns3-MF(Figure. 2). And we successfully demonstrated the cns3-mf transcription and function finally. </p>
 
<p>As is mentioned above, this part is an expression cassette of HisG-MF that is half of Cns3 containing the HisG domain. 2019 SCU-China validated its both in expression and function in  ''Saccharomyces cerevisiae''.To verify it’s function, we did RT-qPCR to detect the existence of Cns3-MF mRNA. (Figure. 1) As for function validation, we performed HPLC to detect PTN, the catalysate of Cns3-MF(Figure. 2). And we successfully demonstrated the cns3-mf transcription and function finally. </p>
−
 
+
</div>
 
[[File:T--SCU-China--scu-demonstration-fig4-1.png|720px]]
 
[[File:T--SCU-China--scu-demonstration-fig4-1.png|720px]]
  

Revision as of 04:33, 21 October 2019


pGAL1-HisG MF-tCYC1

We constructed this part on pYES2 to express HisG-MF in the yeast BY4742.

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal BglII site found at 682
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal AgeI site found at 150
  • 1000
    COMPATIBLE WITH RFC[1000]


iGEM19_SCU-China:

This part is pGAL1-HisG-MF, which is a CDS of HisG-MF with a pGAL1 promoter upstream and a CYC1 terminator downstream. HisG-MF is half of Cns3 containing the HisG domain, which is designed from the reference and has been validated by 2019 SCU-China for expression and function in other fungus.

Cns3 is an enzyme originated from Cordyceps militaris, it catalyzes the biosynthesis of Pentostatin (2’-deoxycoformycin, PTN), an ada chemotherapeutic drug used for the treatment of several forms of leukemia.It has been proved that PTN can protect the stability of cordycepin from deamination by inhibiting adenosine deaminase (ADA) activity in the natural pathway of COR in C.militaris.Therefore, in our designs, we make use of Cns3, producing PTN together with COR in order to guarantee a high yield of COR.Previous studies have also proved that the NK domain of Cns3, one of it's two function domains, is responsible for PTN biosynthesis, which is why we only use part of Cns3.

As is mentioned above, this part is an expression cassette of HisG-MF that is half of Cns3 containing the HisG domain. 2019 SCU-China validated its both in expression and function in Saccharomyces cerevisiae.To verify it’s function, we did RT-qPCR to detect the existence of Cns3-MF mRNA. (Figure. 1) As for function validation, we performed HPLC to detect PTN, the catalysate of Cns3-MF(Figure. 2). And we successfully demonstrated the cns3-mf transcription and function finally.

T--SCU-China--scu-demonstration-fig4-1.png

Figure. 1 RT-qPCR of Cns1\Cns1-2\Cns3-HisG-mf\Cns3-HisG-only.
No-load is the S. cerevisiae without transformed plasmids. The reference gene is PGK1. The RNA of cns1\cns3 are detected successfully.

T--SCU-China--scu-demonstration-fig4-2.png

T--SCU-China--scu-demonstration-fig4-3.png

T--SCU-China--scu-demonstration-fig3.png

Figure. 2 HPLC analysis of PTN
a. Top: Standard sample of 5mM PTN.
Bottom: Supernatant fraction of Cns3-hisG-MF sample. The strain BY4741 was culturing in YPDG media for 3 days.
b. Top: Standard sample of 5mM PTN.
Bottom: Supernatant fraction of Cns3-hisG ONLY sample. The strain BY4741 was culturing in YPDG media for 3 days.
c. Top: Standard sample of 5mM PTN.
Bottom: Supernatant fraction of BY4741 sample. The strain BY4741 was culturing in YPDG media for 3 days.